Crossmark

Increased NHE1 expression is targeted by specific inhibitor cariporide to sensitize resistant breast cancer cells to doxorubicin in vitro and in vivo

Crossref DOI link: https://doi.org/10.1186/s12885-019-5397-7

Published Online: 2019-03-08

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chen, Qi

Liu, Yueqin

Zhu, Xiao-lan

Feng, Fan

Yang, Hui

Xu, Wenlin https://orcid.org/0000-0001-7518-7912
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81672913)

Social Development Project of Jiangsu (BE2018693)

Natural Science Foundation of Jiangsu Province (BK20171311)

Social Development of Zhenjiang (SH2017016)

Medical Development of Jiangsu University (JLY20160022)
License Information

Text and Data Mining valid from 2019-03-08
More Information

Article History

Received: 4 April 2018

Accepted: 20 February 2019

First Online: 8 March 2019

Ethics approval and consent to participate

: All related procedures were performed with the approval of the Human Research Ethics Committee of the Fourth Affiliated Hospital of Jiangsu University. Patients or their relatives were informed of the proper usage of the human breast tissue samples and signed informed consents. Animals used in this study were approved by the Laboratory Animal Management Committee of Jiangsu University and met the guidelines of the National Institutes of Health Guide for the Care and Use of Laboratory Animals. The serial number is UJS-LAER-2016101301.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.